rs10516197
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000513129.1(SLC2A9):c.-41+14357G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.1 in 152,262 control chromosomes in the GnomAD database, including 1,353 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
ENST00000513129.1 intron
Scores
Clinical Significance
Conservation
Publications
- hypouricemia, renal, 2Inheritance: AR, AD, SD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- hereditary renal hypouricemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000513129.1. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.100 AC: 15206AN: 152090Hom.: 1346 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.0556 AC: 3AN: 54Hom.: 0 AF XY: 0.0750 AC XY: 3AN XY: 40 show subpopulations
GnomAD4 genome AF: 0.100 AC: 15235AN: 152208Hom.: 1353 Cov.: 33 AF XY: 0.106 AC XY: 7861AN XY: 74414 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at